Published in Acta Haematol on January 01, 1983
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med (1998) 4.69
Current status of solvent/detergent-treated frozen plasma. Transfusion (1998) 2.24
Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci U S A (1980) 1.90
An international view of hydroxyethyl starches. Intensive Care Med (1999) 1.88
Donation reactions among autologous donors. Transfusion (1990) 1.67
Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics (2000) 1.57
Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr (1996) 1.49
Non-infectious complications of transfusion therapy. Blood Rev (2001) 1.47
Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion (1999) 1.46
Removal of Yersinia enterocolitica from AS-1 red cells. Transfusion (1992) 1.43
Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion (1996) 1.40
Potential for transfusion-associated graft-versus-host disease due to apheresis platelets matched for HLA class I antigens. Transfusion (1994) 1.38
Cytokine generation in stored platelet concentrates. Transfusion (1994) 1.35
An anomaly of neutrophil morphology with impaired function. N Engl J Med (1974) 1.23
Postpartum hemolytic uremic syndrome. Obstet Gynecol (1976) 1.23
Antibodies provoked by the transfusion of biotin-labeled red cells. Transfusion (1999) 1.22
hADA3 is required for p53 activity. EMBO J (2001) 1.22
Measurement of circulating red cell volume using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion (1999) 1.21
Erythropoietin and neonatal anemia. N Engl J Med (1994) 1.18
National survey of neonatal transfusion practices: I. Red blood cell therapy. Pediatrics (1993) 1.17
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17
Circulating red cell volume and red cell survival can be accurately determined in sheep using the [14C]cyanate label. Pediatr Res (1997) 1.16
Etiology of differences in hematocrit between males and females: sequence-based polymorphisms in erythropoietin and its receptor. J Gend Specif Med (2001) 1.16
Occurrence of the release reaction during preparation and storage of platelet concentrates. Vox Sang (1981) 1.14
Pathogen inactivation techniques. Best Pract Res Clin Haematol (2006) 1.12
Purified JC virus T and T' proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology (2000) 1.11
Sterility and quality of blood dispensed in syringes for infants. Transfusion (1986) 1.07
Therapeutic granulocyte transfusions in 1993. Blood (1993) 1.07
Two-dimensional gel electrophoresis and immunoblotting of Campylobacter outer membrane proteins. Infect Immun (1987) 1.05
Cytomegalovirus infection in burn patients. J Burn Care Rehabil (1988) 1.02
The epidemiology of cytomegalovirus infection among patients with burns. Infect Control Hosp Epidemiol (1990) 1.01
Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med (1987) 1.01
Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol (1997) 1.01
Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med (1991) 1.00
Cadaver skin allografts and transmission of human cytomegalovirus to burn patients. J Am Coll Surg (1996) 0.99
Demonstration of granulocyte, monocyte, and endothelial cell antigens by double fluorochromatic microcytotoxicity testing. Transplant Proc (1980) 0.98
Cataracts in neutrophil donors stimulated with adrenal corticosteroids. Transfusion (2001) 0.98
Neonatal transfusions. Vox Sang (2009) 0.97
Efficacy and safety of plateletpheresis by donors with low-normal platelet counts. J Clin Apher (1995) 0.95
Current practice and guidelines for the transfusion of cellular blood components in the newborn. Transfus Med Rev (1989) 0.95
Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion (2001) 0.94
Autologous transfusions for neonates using placental blood. A cautionary note. Am J Dis Child (1992) 0.93
Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev (2001) 0.93
Letter: Activity of 5'nucleotidase in polymorphonuclear leukocytes. Blood (1975) 0.92
Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion (1995) 0.92
Moderate and severe reactions during autologous blood donations are no more frequent than during homologous blood donations. Vox Sang (1990) 0.92
Infections in patients with neutropenia. Am J Dis Child (1977) 0.91
Blood donations, safety, and incentives. Transfusion (2001) 0.91
Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group. Transfusion (1992) 0.91
[14C]cyanate labeling of sheep red cells: covalent binding to hemoglobin continues in vivo for a day. Pediatr Res (1997) 0.89
Plasma fibronectin level and clinical status in cardiac surgery patients. J Lab Clin Med (1983) 0.88
A survey to identify deficiencies in transfusion medicine education. Acad Med (1989) 0.88
Letter: Abuse of salt "substitute". N Engl J Med (1975) 0.87
Chemotactic peptide binding by intact neutrophils from human neonates. Pediatr Res (1984) 0.87
Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion (1981) 0.87
Current issues in neonatal transfusions. Vox Sang (1986) 0.86
Cost-effectiveness of a limited-donor blood program for neonatal red cell transfusions. Transfusion (1999) 0.86
Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion (1993) 0.86
Probable reasons that autologous blood was not donated by patients having surgery for which crossmatched blood was ordered. Transfusion (1992) 0.85
Isolation and flow cytometric analysis of T-cell-depleted CD34+ PBPCs. Transfusion (2000) 0.85
The effect of mode of agitation and type of plastic bag on storage characteristics and in vivo kinetics of platelet concentrates. Transfusion (1986) 0.84
Multiple transfusion fail to provoke antibodies against blood cell antigens in human infants. Transfusion (1986) 0.84
Persistent neutrophil dysfunction in an adult. Combined defect in chemotaxis, phagocytosis and intracellular killing. Am J Med (1974) 0.84
Guidelines for auditing pediatric blood transfusion practices. Am J Dis Child (1991) 0.84
Granulocyte antigens detected by cytotoxicity (GCY) and capillary agglutination (CAN). Transplant Proc (1978) 0.84
Education in transfusion medicine for medical students and doctors. Vox Sang (2013) 0.84
Comparison of muscle sympathetic responses to hemorrhage and lower body negative pressure in humans. J Appl Physiol (1985) (1991) 0.84
Recommended methods for conducting radiolabeled platelet survival studies. Transfusion (1986) 0.83
Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion (1985) 0.83
Oxygen-detoxifying enzymes in neutrophils of infants and their mothers. J Lab Clin Med (1980) 0.83
Iron deficiency, infections, and immune function: a reassessment. Am J Clin Nutr (1978) 0.83
Role of microaggregate blood filtration in clinical medicine. Transfusion (1984) 0.83
Activation of platelet concentrate during preparation and storage. Blood Cells (1992) 0.82
International forum: granulocyte transfusions. Vox Sang (2000) 0.82
Extended storage of platelets in a new plastic container. II. In vivo response to infusion of platelets stored for 5 days. Transfusion (1985) 0.82
Ingestion of hydroxyethyl starch by human leukocytes. Transfusion (1986) 0.81
An intrinsic coagulation pathway inhibitor in a 3-year-old child. Am J Clin Pathol (1979) 0.81
Status epilepticus in pregnancy: effect of phenytoin malabsorption on seizure control. Neurology (1978) 0.81
Activation and activity of the superoxide-generating system of neutrophils from human infants. Pediatr Res (1983) 0.81
The value of postoperative red cell transfusions is unclear. Transfusion (1993) 0.81
Blood component therapy during the neonatal period: a national survey of red cell transfusion practice, 1985. Transfusion (1990) 0.81
New granulocyte antigens demonstrated by microgranulocytotoxicity assay. J Clin Invest (1980) 0.81
The elimination of hydroxyethyl starch from the blood donors experiencing single of multiple intermittent-flow centrifugation leukapheresis. Transfusion (1981) 0.80
The cellular and molecular basis of the platelet storage lesion: a symposium summary. Transfusion (1992) 0.80
Nutrient deficiencies in breast-fed infants. N Engl J Med (1978) 0.80
Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion (1994) 0.80
A survey of Canadian neonatal blood transfusion practices. Transfus Sci (1997) 0.80
A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors. Transfusion (1986) 0.80
Effect of mode of agitation on storage of platelet concentrates in PL-732 containers for 5 days. Vox Sang (1983) 0.80
Hydroxyethyl starch accentuates von Willebrand's disease. Transfusion (1985) 0.79
Neutrophil chemiluminescence during the first month of life. Acta Haematol (1980) 0.79
Effects of intensive granulocyte donation on donors and yields. Transfusion (1986) 0.79
Biological mothers may be dangerous blood donors for their neonates. Acta Haematol (1991) 0.79
Neutrophil assays as modified for infants. J Clin Lab Immunol (1980) 0.79
Granulocyte-specific antigens detected by microgranulocytotoxicity. Transplant Proc (1979) 0.79
Autologous blood perfusion for myocardial protection during coronary angioplasty: a feasibility study. Circulation (1987) 0.79